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Association BetweenMethod of Prescribing
and Primary Nonadherence to DermatologicMedication
in an Urban Hospital Population
Adewole S. Adamson, MD, MPP; Elizabeth A. Suarez, MPH; April R. Gorman, MS
IMPORTANCE Prescription underuse is associated with poorer clinical outcomes. A significant
proportion of underuse is owing to primary nonadherence, defined as the rate at which
patients fail to fill and pick up new prescriptions. Although electronic prescribing increases
coordination of care and decreases errors, its effect on primary nonadherence is less certain.
OBJECTIVES To analyze factors associated with primary nonadherence to dermatologic
medications and study whether electronic prescribing affects rates of primary nonadherence.
DESIGN, SETTING, AND PARTICIPANTS A retrospective review ofmedical records was
conducted from January 1, 2011, to December 31, 2013, among a cohort of new patients
prescribed dermatologic medications at a single, urban, safety-net hospital outpatient
dermatology clinic.
MAIN OUTCOMES ANDMEASURES The primary outcomewas the overall rate of primary
nonadherence, defined as filling and picking up all prescribedmedications within a 1-year
period, and the difference in primary nonadherence between patients who received
electronic prescriptions and those who received paper prescriptions. Secondary outcomes
included the association of primary nonadherence with sex, age, relationship status, primary
language, race/ethnicity, and number of prescriptions.
RESULTS A total of 4318 prescriptions were written for 2496 patients (mean [SD] age,
47.7 [13.2] years; 849men and 1647 women). The overall rate of primary nonadherence was
31.6% (n = 788). Based onmultivariable analysis, the risk of primary nonadherence was 16
percentage points lower among patients given an electronic prescription (15.2%) than
patients given a paper prescription (31.5%). Primary nonadherence decreased with age
(<30 y, 38.9%; 30-49 y, 35.3%; and 50-69 y, 26.3%), and then increased in elderly patients
70 years and older (31.9%). Of patients who were given 1, 2, 3, 4, or 5 prescriptions, rates of
primary nonadherence were 33.1%, 28.8%, 26.4%, 39.8%, and 38.1%, respectively. Primary
nonadherence decreased with age but then increased in elderly patients. Patients identifying
English as their primary language had the highest rate of primary nonadherence (33.9%)
compared with Spanish (29%) or other speakers (20.4%).
CONCLUSIONS AND RELEVANCE Comparedwith paper prescriptions, electronic prescriptions
were associated with less primary nonadherence. Number of prescriptions, language,
race/ethnicity, and age were associated with increased rates of primary nonadherence.
Efforts must bemade to understand why primary nonadherence occurs, identify patients
prone to primary nonadherence, and simplify medication regimens to maximize adherence
and quality of care.
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A s the health care system in the United States hasincreasingly moved to the use of electronic medicalrecords, electronic prescribing (e-prescribing) has
become an important part of improving quality of care and
the patient experience. Electronic prescribing increases
coordination between pharmacist and physician and can
decrease prescription errors.1,2 However, it is less certain
how e-prescribing affects the rate at which patients fill (pri-
mary adherence) or do not fill (primary nonadherence) their
new prescriptions.3
Although it may seem intuitive that primary adherence
would increaseby removing thepatient fromtheprescription-
to-pharmacy routingprocess, few studies have comparedpri-
mary nonadherence of patients given traditional paper pre-
scriptionsvse-prescriptions.Of these studies, therehavebeen
mixed results regarding the use of e-prescriptions,with some
showing increased primary adherence, others showing de-
creased primary adherence, and still others showing no
difference.4-7
Understanding the epidemiologic factors of prescrip-
tions is important because underuse of prescription medica-
tionscontinues tobeaproblem.Underuseofprescriptionmedi-
cations has been linked to poorer patient outcomes and
increased health care costs.8 Most studies examining nonad-
herence focusonmedicationusepatternsamongpatientswho
have already filled their prescriptions.9-14 Fewer studies fo-
cus strictly on primary nonadherence. In dermatology, only a
few, mostly small studies have specifically investigated pri-
mary nonadherence.15-17
In this study, we measure primary nonadherence to der-
matologic medications by examining prescription data from
a large, urban county hospital system with an enclosed pre-
scription environment. Patient and prescription characteris-
tics were evaluated to assess factors associated with primary
nonadherence.
Methods
PatientsontheParklandHealthPlus (PHP)program,ataxpayer-
subsidized health insurance program for uninsured, low-
incomeresidentsofDallasCounty,Texas,were included in this
study.Aspart of PHP,patients receive aprescriptiondrugben-
efit at considerably reduced cost if they fill their prescrip-
tions througha closedpharmacy system.Data fromthe closed
pharmacy systemwere linkedwith theelectronicmedical rec-
ord system of ParklandHealth andHospital System in Dallas,
Texas, for this analysis.Onlynewpatients atPHPseenbyader-
matologist in theoutpatientdermatologyclinicatParklandMe-
morial Hospital were included. Newpatientswere defined by
not having a visit to the clinic in the prior 3 years. The index
visit was defined as a visit by a new patient occurring from
January 1, 2011, to December 31, 2013, duringwhich 1 ormore
dermatologicmedicationswere prescribed. Patientswere ex-
cluded if they did not have a medication prescribed at their
visit.Nonformularymedicationswereexcludedfromtheanaly-
sis. Patients’ age, sex, self-reported race/ethnicity, relation-
ship status (married, common law, or significant relationship
[eg, domestic partnership or civil union] vs divorced, legally
separated,single,orwidowed),primary languagespoken,num-
ber of dermatologic prescriptions, type of prescription given
(electronic or paper), anddate ofmedicationpick-upwere ex-
tracted from the linked electronic medical record and phar-
macy record.
Primarynonadherencewasdefinedasnot filling andpick-
ing up all dermatologic prescriptions obtained during the in-
dexvisitwithin 1 year of theprescriptiondate.Adherencewas
further classified as full adherence (filling all prescriptions),
some adherence (filling some but not all prescriptions), and
complete nonadherence (filling none of the prescriptions).
Demographic andprescription characteristics and their crude
association with primary nonadherence were assessed using
Mantel-Haenszel general association tests for categorical vari-
ablesandanalysisofvariance forcontinuousvariables.Weused
linear regression models (with identity and log link func-
tions) to estimate crude and adjusted risk differences and risk
ratioswith95%CIs for theriskofprimarynonadherenceamong
patientswith e-prescriptions vspaper prescriptions. Thevari-
ables included in the analysis were age, sex, race/ethnicity,
marital status, and primary language spoken. Kaplan-Meier
product limit survival curves were created for time (in days)
until all prescriptionswere filled.Datamanagementandanaly-
sis was performed with SAS, version 9.3 (SAS Institute Inc).
The studywas approved by theUniversity of Texas South-
westernMedicalCenterInstitutionalReviewBoard.Owingtothe
retrospectivenature of the study, patient consentwasnotnec-
essary.Adatauseagreementwasalsoapprovedforuseofthede-
identifieddataatTheUniversityofNorthCarolinaatChapelHill.
Results
Atotalof2496patientsmet the inclusioncriteria andwerepre-
scribed a total of 4318 medications for dermatologic condi-
tions, at ameanof 1.7 prescriptionsperpatient. Themean (SD)
age of patients was 47.7 (13.2) years, and the majority were
women (1647 [66%]). Consistent with the population served
by this health system, nearly half of patients (1220 [48.9%])
were Hispanic, and the rest were black (654 [26.2%]), white
(443 [17.7%]), or other race/ethnicity (179 [7.2%]). The most
common primary language was English (1468 [58.8%]), fol-
lowed by Spanish (920 [36.9%]) (Table 1). Most encounters
involved printed prescriptions (1693 [67.8%]). Overall, 3254
Key Points
Question Are patients more likely to fill and pick upmedications if
they receive a paper prescription or an electronic prescription?
Findings In this record review of 2496 patients with a highly
subsidized pharmaceutical benefit plan seen at the dermatology
clinic of a county hospital, there was a 47% reduction in primary
nonadherence if the prescription was in electronic format
compared with a paper prescription.
Meaning Patients are more likely to fill and pick upmedications if
they are prescribed in an electronic format.
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prescriptions (75.4%) were filled and picked up. The patient-
level primary adherence ratewas 68.4% (n = 1708). Of thepa-
tientswhowerenonadherent, 169 (6.8%) filled andpickedup
someof their prescriptionswhile619 (24.8%) filledandpicked
up none.
Sex and relationship statuswerenot associatedwith adif-
ference in primary nonadherence. Rates of primary nonad-
herence decreased with increasing age (<30 years, 67 of 231
[29%]; 30-49 years, 295 of 1100 [26.8%]; 50-69 years, 237 of
1096 [21.6%]; and≥70years, 20of69 [29%]). Patientswhodid
not speak English had lower rates of primary nonadherence
(Spanish, 221 of 920 [24%]; other language, 20of 108 [18.5%])
comparedwith thosewho identified English as their primary
language (378of 1468 [25.7%]).Hispanicpatientshad thehigh-
est full adherence rate (858 of 1220 [70.3%]) of any racial/
ethnic group (Table 2).
Table 2. Adherence by Patient and Prescription Characteristics
Characteristic
No. (%)
P ValueaAdherent Some Adherence
Completely
Nonadherent
Prescription type
Paper 1064/1693 (62.8) 137/1693 (8.1) 492/1693 (29.1)
<.001
Electronic 644/803 (80.2) 32/803 (4.0) 127/803 (15.8)
Age, y
<30 142/231 (61.5) 22/231 (9.5) 67/231 (29.0)
<.001
30-49 712/1100 (64.7) 93/1100 (8.5) 295/1100 (26.8)
50-69 807/1096 (73.6) 52/1096 (4.7) 237/1096 (21.6)
≥70 47/69 (68.1) 2/69 (2.9) 20/69 (29.0)
Sex
Female 1117/1647 (67.8) 119/1647 (7.2) 411/1647 (25.0)
.41
Male 591/849 (69.6) 50/849 (5.9) 208/849 (24.5)
Language
English 969/1486 (66.0) 121/1486 (8.2) 378/1486 (25.7)
<.001Spanish 653/920 (71.0) 46/920 (5.0) 221/920 (24.0)
Other 86/108 (79.6) 2/108 (1.9) 20/108 (18.5)
Race/ethnicity
Non-Hispanic white 288/443 (65.0) 19/443 (4.3) 136/443 (30.7)
.007
Hispanic white 858/1220 (70.3) 79/1220 (6.5) 283/1220 (23.2)
Black 437/654 (66.8) 57/654 (8.7) 160/654 (24.5)
Other 125/179 (69.8) 14/179 (7.8) 40/179 (22.3)
Relationship status
In a relationship 752/1067 (70.5) 55/1067 (5.2) 260/1067 (24.4)
.01
Not in a relationship 956/1429 (66.9) 114/1429 (8.0) 359/1429 (25.1)
a Mantel-Haenszel general
association test.
Table 1. Characteristics of the Study Population by Prescription Type
Characteristic Electronic Prescription (n = 803)a Paper Prescription (n = 1693)a P Valueb
Sex
Female 532 (66.3) 1115 (65.9)
.85
Male 271 (33.7) 578 (34.1)
Age, mean (SD), y 48.2 (13.3) 47.5 (13.1) .18
Primary language
English 480 (59.8) 988 (58.4)
.78Spanish 290 (36.1) 630 (37.2)
Other 33 (4.1) 75 (4.4)
Race/ethnicity
Non-Hispanic white 162 (20.2) 281 (16.6)
.12
Hispanic white 387 (48.2) 833 (49.2)
Black 195 (24.3) 459 (27.1)
Other 59 (7.3) 120 (7.1)
Relationship status
In a relationship 335 (41.7) 732 (43.2)
.47
Not in a relationship 468 (58.3) 961 (56.8)
a Data are presented as number
(percentage) of patients unless
otherwise indicated.
bMantel-Haenszel general
association test for categorical
variables and analysis of variance for
continuous variables.
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Theriskofprimarynonadherencewas17percentagepoints
loweramongpatientsgivenane-prescriptionthanpatientsgiven
apaper prescription. This differencewas 16percentagepoints
in the adjusted analysis. This finding represents a 47% reduc-
tion in the risk of primary nonadherence for patients who re-
ceivedane-prescriptionvsthosewhoreceivedapaperprescrip-
tion.Patientswithpaperprescriptionshadahigherproportion
of full adherence in the first 4 days after the prescriptionwas
issued, but after this point, patientswith e-prescriptionswere
muchmore likely to be fully adherent (Figure).
Primary adherence was 66.9% (864 of 1291) when 1 pre-
scription was given and increased to 71.2% (553 of 777) when
2and73.6%(201of273)when3prescriptionsweregiven;how-
ever, primary adherence declined to 60.2% (77 of 128) when
4 prescriptions were given (Table 3).
Discussion
In this studymeasuringratesofprimarynonadherencetomedi-
cations prescribed bydermatologists,we found a 31.6% rate of
primary nonadherence, defined as failing to fill and pick up all
prescriptionswithin 1 year of receiving the prescriptions. This
rate isslightlygreater thanthe20%to30%ratesofprimarynon-
adherence reported inprevious studies specifically investigat-
ingdermatologicmedications.15-17However,someofthesestud-
ieswerelimitedbyself-reportedresponsebias,whichcouldhave
underestimated the level of primary nonadherence. In fact,
1studyshowedthat,althoughpatientsself-reportedarateofpri-
marynonadherenceof6.2%,whenpharmacyrecordswereque-
riedforexternalvalidation, ratesofprimarynonadherencewere
45%and25%at2weeksand6months, respectively.16 It isoften
difficult to compare adherence studies directly givendifferent
follow-uptimes, studypopulations, andreliabilityofoutcomes
measured(eg,surveysvsclaimsvsdirectpharmacydata).More-
over, unlike many primary nonadherence studies, our unit of
analysis fordefiningnonadherencewasat thepatient level,not
theprescription level.Whencomparedat theprescription level,
ourstudypopulationshowssimilar ratesofnonadherenceasre-
portedinotherstudies. Inourstudy,24.6%ofprescriptionswent
unfilled,which is lower than the rateofprimarynonadherence
to dermatologicalmedications of 31.2% reported by Fischer et
al,18 27.8% reported byTamblyn et al,19 and29.2% reported by
Stormetal.17This comparable levelofprimarynonadherence is
remarkablegiventhelow-incomedemographicofpatients inour
study. Patientswith lower incomes are oftenmore sensitive to
prices, and our results are likely owing to the subsidized phar-
macy benefit received by patients for theirmedications.
Similar to Anderson et al,15 we found a decrease in pri-
mary nonadherence to dermatologic medication with use of
e-prescriptions.Wealso foundthat,during the first4days from
the indexvisit, patientswithpaper prescriptions had ahigher
rate of full adherence. Although this study was not designed
to establish a cause, it is possible that having apaper prescrip-
tion served as a tangible reminder for patients to fill and pick
up their prescription in the short term. However, in the lon-
ger term, lost ormisplacedpaper prescriptions couldhave led
to a diminished likelihood of full adherence.
The effect of e-prescribing on primary nonadherence has
been variable, with studies showing increased, decreased, or
unchanged rates of primarynonadherence.4-7 For example, in
a prospective study conducted in an emergency department,
while pharmacy wait times and patient satisfaction im-
proved, therewasnodifference in rates of primarynonadher-
encebetweene-prescriptions andpaperprescriptions.4 In an-
other example, a large cross-sectional cohort studyexamining
the characteristics of abandoned prescriptions showed that
e-prescriptions were more likely to be abandoned at the
pharmacy.6 It is possible that the variability in primary non-
Figure. Time Until Medication Fill for Fully Adherent Patients
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medications prescribed) for 60 days after the index visit. There was a
statistically significant difference at 60 days (Wilcoxon test; P < .001).
Table 3. Number ofMedications Filled According to the Number ofMedications Prescribed
Medications Prescribed, No.
Medications Filled, No. (%)
0 1 2 3 4 5 6 7
1 (n = 1291) 427 (33.1) 864 (66.9)
2 (n = 777) 142 (18.3) 82 (10.6) 553 (71.2)
3 (n = 273) 34 (12.5) 8 (2.9) 30 (11.0) 201 (73.6)
4 (n = 128) 15 (11.7) 0 6 (4.7) 30 (23.4) 77 (60.2)
5 (n = 21) 1 (4.8) 0 0 1 (4.8) 6 (28.6) 13 (61.9)
6 (n = 5) 0 0 0 1 (20.0) 0 4 (80.0) 0
7 (n = 1) 0 0 0 0 0 0 1 (100) 0
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adherence is owing to different populations being studied or
different study designs, such as reliance on patient self-
reports, for measuring rates of primary nonadherence.
Anotable findingofour study is thedecrease in ratesofpri-
mary nonadherence when patients are given between 1 and 3
prescriptions, followed by an increase in rates of primary non-
adherence when they are given more than 3 prescriptions
(Table3).Thenumberofdispenseddrugs isassociatedwithpri-
mary nonadherence.20 Polypharmacy is a well-documented
problem in patients’ compliance with complex treatment
regimens.21,22 Patients on the PHP plan pay $5 per prescrip-
tion,whichcouldexplainincreasednonadherencebeyond3pre-
scriptions. Cost is amajor consideration formany patients. Up
to 32% of older patients take less medication than prescribed
to reduce costs.23 Although patients in our study are buffered
from high medication costs, multiple medications can be-
come financially burdensome.
Similar to other studies of primary nonadherence,we did
not find a sex difference in rates of primary nonadherence;
however, younger patients had higher rates of primary
nonadherence.15,18 In our study,Hispanic patients had among
the lowest rateofprimarynonadherence.This finding is incon-
trast to other reports that show higher rates of primary non-
adherence among Hispanic patients.24,25 However, a similar
finding has been reported for rates of primary nonadherence
to cardiac medications within the PHP population.26 Adher-
ence is multifactorial and complex, but it is possible that ad-
herence of Hispanic patients is higher because Parkland Me-
morial Hospital has the infrastructure to accommodate the
needs of its high volumeof Spanish-speaking patients. Socio-
cultural differences of non–English-speakingpatients in their
trust of physician recommendations could also have posi-
tively influenced primary adherence.
Limitations
This study has some limitations. The insurance coverage
environment allowed for direct study of nonadherence;
however, this distinctiveness makes the study less general-
izable as it exclusively encompasses a population of poor
residents of Dallas County in one subspecialty clinic receiv-
ing a subsidized pharmacy benefit. Sixty-six percent of
study participants were female, and the racial demograph-
ics included 48.9% Hispanic and 26.2% black patients,
which may not be representative of other dermatology clin-
ics. It is possible that there were other factors not captured
in the data that could have resulted in the difference in
adherence rates. Misclassification of medications as unfilled
could have resulted if prescription adjustments were made
by telephone after initial visit. Finally, while this study
uncovered factors associated with primary nonadherence,
it was not designed to understand the reasons for patient
nonadherence.
Conclusions
Electronic prescribing has becomeone of themajor criteria to
evaluatemeaningfuluseof electronichealth recordsbyhealth
care professionals.27 In this study, we demonstrated that
e-prescribing is associatedwith reduced rates of primarynon-
adherence. As the health care system transitions from paper
prescriptions to directly routed e-prescriptions, it will be im-
portant to understand how that experience affects patients,
particularly their likelihood of filling the prescriptions. Pri-
marynonadherence isacommonandpervasiveproblem.Steps
should be taken to better understandwhyprimarynonadher-
ence happens and how it can be improved.
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NOTABLENOTES
TheHistory of JohnHansMenkes andKinkyHair Syndrome
Parth Patel, BS; Arpan V. Prabhu, BS; Thomas G. Benedek, MD
JohnHansMenkeswasapediatricneurologist,born inVienna,Austria, in
1928.FollowingtheGermanannexationofAustria,Menkes immigratedto
theUnitedStateswithhisfamily in1939attheageof11years.Hecompleted
highschoolinCaliforniaandsubsequentlyearnedundergraduateandgradu-
atedegrees inorganic chemistry at theUniversity of SouthernCalifornia.
Althoughheheldapassion forwritingand journalism,Menkesultimately
decidedtofollowthefamilytraditionofstudyingmedicine.1Followingape-
diatricneurologyresidencyatColumbia-PresbyterianMedicalCenterinNew
York,Menkeswent to theUniversity of California, LosAngeles,wherehe
spenttherestofhis lifeadvancingthefieldofpediatricneurologyandhav-
ing an impact on the fields of genetics anddermatology.
Menkes’ chiefcontributiontomedicinewashisdiscoveryofkinkyhair
syndromeorMenkesdisease. In 1962,Menkesencounteredamale infant
who, while developmentally normal at birth, quickly developed floppy
muscle tone, seizures, andcoarse,brittlehair.1,2Menkes learned that the
infant’s4malesiblings,alsoyoungchildren,hadverysimilarphysicalmani-
festations,suggestinganX-linkedgeneticdisorder.ThroughMenkes’s fur-
ther investigationsandthecontributionsofother researchers, it isknown
today thatMenkesdisease results fromageneticmutation in theATP7A
gene,which is responsible for producing anenzyme that regulates cop-
per levels in the body. This subsequent deficiency in copper transport
across cells ultimatelydeprives thebrain andother tissuesof this impor-
tantmineral, explaining the symptoms thatMenkes observed.3
Menkes is famous for othermedical achievements, such as describ-
ing the first known cases of maple syrup urine disease while he was an
intern in 1954.1 This autosomal recessive disorder is due to a disruption
in themetabolism of branched-chain amino acids, leading to a buildup
of isoleucyl ketoacid that gives the urine its characteristic odor.
Menkes’s contributions to society were not limited to medicine, as
hewas also highly regarded for his contributions to the humanities. His
passion for writing did not falter as he aged, and hewrote 3 novels and
3 plays that were produced in Los Angeles. One of these productions,
titled The Last Inquisitor, was aHolocaust drama thatwon a prestigious
Drama-LogueAward; thiswasa theater award for aplay selectedby the-
ater critics of the Drama-Logue newspaper, a weekly west-coast the-
ater trade publication. In addition,Menkes served as an expert witness
for plaintiffs in trials involving damage resulting from vaccines andwas
appointed to the National Institute of Medicine’s Forum for Vaccine
Safety.1
Menkes was named the director of pediatric neurology at Los An-
geles’ Cedar-Sinai Medical Center in 1997. He died of colon cancer and
complicationsof chemotherapy inNovemberof2008, 1month fromhis
80th birthday.
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